Immune thrombocytopenia
Conditions
Interventions
Treatment group:Prednisone acetate + Jiawei Guipi Mixture
Control group:Prednisone acetate + Chinese medicine placebo
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of ITP; 2. Meet the diagnostic criteria for TCM syndrome evaluation of this topic; 3. The principle of informed consent; 4. Age 18-70 years old; 5. All primary patients.
Exclusion criteria
Exclusion criteria: 1. Secondary thrombocytopenia, such as liver cirrhosis, hypersplenism, rheumatic immune system diseases, drug-induced thrombocytopenia, hematological tumors, etc; 2. Patients with multiple organic lesions or functional deficiencies; 3. Individuals with allergies to the drugs in this experiment; 4. Those who do not follow medical advice or use other treatment measures that affect the efficacy during the treatment period; 5. Pregnant or lactating women; 6. Patients with critical illness, cerebral hemorrhage or severe visceral bleeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficacy;Effect of TCM syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vascular endothelial function;Bleeding symptom score;Hormone abatement rat;Safety indicators; | — |
Countries
China
Contacts
Public ContactHuajie Tian
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed